UBS Group’s Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock VHAQ.U Stock Holding History

UBS Group’s Portfolio VHAQ.U Stock Details VHAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,257	Closed	-$190K	–	11379
2022 Q3	$190K	Hold	18,257	–	–	﹤0.01%	5136
2022 Q2	$190K	Hold	18,257	–	–	﹤0.01%	4967
2022 Q1	$168K	Sell	18,257 -1,171	-6%	-$12.1K	﹤0.01%	5496
2021 Q4	$202K	Hold	19,428	–	–	﹤0.01%	5677
2021 Q3	$201K	Hold	19,428	–	–	﹤0.01%	5309
2021 Q2	$204K	Sell	19,428 -1,700	-8%	-$17.7K	﹤0.01%	5329
2021 Q1	$218K	Buy	21,128 +6,128	+41%	+$64.5K	﹤0.01%	5420
2020 Q4	$154K	Buy	+15,000	New	+$154K	﹤0.01%	5409

Other funds holding VHAQ.U

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group's VHAQ.U Position: Q4 2022 in Review

UBS Group sold out of Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) in Q4 2022, closing a stake of 18,257 shares — an estimated $190K sold.

UBS Group first reported a position in VHAQ.U in Q4 2020 and held it in 8 quarters. The position peaked at $218K in Q1 2021. 1 fund tracked by Wall St. Rank holds VHAQ.U as of Q4 2022.

UBS Group reported no remaining Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 18,257 Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock shares in Q4 2022, an estimated $190K.
UBS Group first reported a position in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock in Q4 2020 and held it in 8 quarters.
UBS Group's Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position peaked at $218K in Q1 2021.
1 fund tracked by Wall St. Rank held Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.